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Smoking and the compression of morbidity
W J Nusselder, C W N Looman, P J Marang-van de Mheen, H van de Mheen,
J P Mackenbach
Abstract
Objective—To examine whether eliminat-
ing smoking will lead to a reduction in the
number of years lived with disability (that
is, absolute compression of morbidity).
Design—Multistate life table calculations
based on the longitudinal GLOBE study
(theNetherlands)combinedwith theLong-
itudinal Study of Aging (LSOA, United
States of America).
Setting—the Netherlands.
Subjects—Dutch nationals aged 30–74
years living in the city of Eindhoven and
surrounding municipalities (GLOBE) and
United States citizens age 70 and over
(LSOA).
Main outcome measures—Life expect-
ancy with and without disability and total
life expectancy at ages 30 and 70.
Results—A non-smoking population on
balance spends fewer years with disability
than a mixed smoking-non-smoking
population. Although non-smokers have
lower mortality risks and thus are exposed
to disability over a longer period of time,
their lower incidence of disability and
higher recovery from disability yield a net
reduction of the length of time spent with
disability (at age 30: −0.9 years in men and
−1.1 years in women) and increases the
length of time lived without disability (2.5
and 1.9 years, for men and women,
respectively). These outcomes indicate
that elimination of smoking will extend
life and the period of disability free life,
and will compress disability into a shorter
period.
Conclusions—Eliminating smoking will
not only extend life and result in an
increase in the number of years lived
without disability, but will also compress
disability into a shorter period. This
implies that the commonly found trade oV
between longer life and a longer period
with disability does not apply. Interven-
tions to discourage smoking should re-
ceive high priority.
(J Epidemiol Community Health 2000;54:566–574)
Today, the aim of science and medicine is more
to reduce the number of years that people
spend diseased or disabled than to lengthen
life.1 Evidence is mounting that smoking is not
only a major preventable factor associated with
mortality,2 3 but also with disability.4–8 Although
a large body of evidence supports the claim that
not smoking extends the length of life,2 9 it is
not certain whether not smoking also reduces
the number of years spent with disability. Given
the fact that non-smokers live longer, these
extra years may be accompanied by an
increased burden of disability. After all, survi-
vors age and increasing age is strongly
associated with chronic diseases and disability.
Hence, whether eliminating smoking will on
balance result in a reduction of the length of
time lived with disability, depends on whether
or not the fewer number of years with disability
attributable to lower risks of disability are
counterbalanced by the rise in the number of
years with disability attributable to improved
chances of surviving to older age.
We used a multistate life table to estimate the
eVect of not smoking on total life expectancy
and life expectancy with and without disability,
taking into account the fact that smoking
causes both excess disability and mortality. The
central question is whether eliminating smok-
ing will lead to a reduction in the number of
years with disability (that is, compression of
morbidity).
Methods
SOURCE OF DATA
The primary data source used was the GLOBE
study—GLOBE being the Dutch acronym for
Health and Living Conditions of the popula-
tion of Eindhoven and surroundings. A de-
tailed description of the sample and design is
given elsewhere.10 A postal questionnaire was
sent in 1991 to an aselect sample of approxi-
mately 27 000 Dutch nationals aged 15–74
years living in the city of Eindhoven and
surrounding municipalities (response rate
70.1%). Persons living in institutions were
included in this sample, except for the city of
Eindhoven (40% of all respondents), where
homes for the elderly were the only institutions
that could be included. Two sub-samples of the
postal survey were approached for an addi-
tional oral interview. The first sub-sample was
formed by a group that was taken at random
from respondents of the postal survey (3529
persons). The response rate of this oral
interview was 79.3% (2800 respondents). In
the second sub-sample (also taken from
respondents of the postal survey), chronically
ill persons were oversampled (3970 respond-
ents). To increase the power of our study, we
also included the second sub-sample. The
response of the oral interview of this second
group was 72.2% (2867 respondents). In the
follow up, respondents of both sub-samples of
the 1991 oral interview (5667) received postal
questionnaires in 1993 (n=4496, that is,
79.4%; 81.1% after correction for mortality)
and 1995 (n=4105, that is, 72.4%; 76.4% after
correction). As mortality is an outcome of
interest, persons who died were not considered
as “lost to follow up” and were included in the
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corrected response rate. Information on mor-
tality was based on municipal population regis-
ters, disability status was assessed in each wave,
and smoking status was based on the postal
questionnaire of 1991. Smoking status was
classified as “current smokers” and “non-
smokers”. We did not use a reference group of
persons who had never smoked in order to
avoid small numbers and bias resulting from
the considerable misclassification of former
smokers as persons who had never smoked,
which reportedly is common in survey data.11
Persons under age 30 (n=659) and persons of
whom the vital status at follow up was
unknown (less than 0.3%) were excluded from
the analyses. Persons were considered to be
disabled if they were living in an institution or
indicated that they needed help or were unable
to perform without (great) diYculty one or
more activities of daily life, mobility and com-
munication that are essential for independent
functioning. In 1991, the complete set of ques-
tions on disability was presented to only 2867
subjects (second sub-sample). Complete infor-
mation on disability and vital status at the
beginning and end of a two year interval was
available on 1988 persons in the period 1991–
1993 and on 3119 persons in the period 1993–
1995, yielding a total of 5107 observations.
As GLOBE did not comprise persons above
age 74 in 1991 and a substantial part of the
possible mortality and disability reduction
attributable to smoking elimination may occur
beyond age 75, a second data source, the Long-
itudinal Study of Aging (LSOA)12 was used.
The LSOA started in 1984 with interviews of
7527 non-institutionalised persons of age 70
and over in the United States of America. Sub-
jects who were institutionalised during the
study were included in the follow up. The
complete sample was reinterviewed in 1988
(n=4984, 66.2%; 89.0% after correction for
mortality) and 1990 (n=4142, that is, 55.0%;
87.4% after correction), while a sub-sample of
5151 persons was reinterviewed in 1986
(n=4113, that is, 79.8%; 92.4% after correc-
tion). Disability status was assessed in each
wave in a similar way as in the GLOBE study,
and information on mortality was based on the
National Death Index. Smoking status was not
assessed in LSOA. Full details on the sample
and design are given elsewhere.13 Non-whites
(n=647) and persons of whom the vital status
at follow up was unknown (less than 0.4%)
were excluded from the analyses. Complete
information on disability and vital status was
available for 3720 persons in 1984–1986, 2853
in 1986–1988 and 3535 in 1988–1990, yield-
ing a total of 10 108 observations.
STUDY DESIGN
Firstly, we examined whether the two datasets
could be joined and whether they would
together describe the Dutch situation by com-
paring the proportion of persons who died and
the proportion of disabled persons by age
between GLOBE, LSOA and national rep-
resentative data sources.14–16 As these condi-
tions were met, except for a small jump in the
prevalence of disability between LSOA and
GLOBE in men, and lower proportions of
women who died in LSOA (most likely because
of the underrepresentation of the insitutional-
ised population)17 we pooled all observations.
We estimated incidence rates of disability,
recovery rates from disability and mortality
rates among non-disabled and disabled per-
sons for the current mixed smoking-non-
smoking population, using Poisson regression
analysis. This method is also known as log lin-
ear regression with oVset.18 The number of
persons at risk, used as rate multiplier in the
regression analysis, was adjusted for the
sampling design in LSOA and for the overrep-
resentation of people with a chronic disease in
the second sub-sample in GLOBE. An adjust-
ment was also made for persons for whom the
disability status was unknown at the beginning
or end of the interval, but who were known to
be alive. The equations used to describe the
relation with age and the estimated parameters
are given in the appendix. We used the
multistate life table, which is an extension of
the standard life table,19 to estimate life expect-
ancy with and without disability for the current
mixed population on the basis of these age spe-
cific incidence, recovery and mortality rates.
The close agreement between model estimates
of total life expectancy, as well as outcomes of
more detailed validity checks (see Discussion
section) induced us to consider the estimated
multistate life table model to represent the
Dutch situation.
Next, the incidence, recovery and mortality
rates among non-disabled and disabled per-
sons were estimated for non-smokers to calcu-
late life expectancy with and without disability
after smoking elimination. These rates for non-
smokers were estimated from the rates in the
mixed population, combined with data on the
percentage of smokers and non-smokers in the
mixed population20 (table 1), and data on the
association between smoking and incidence,
recovery and mortality among non-disabled
and disabled persons (expressed as rate ratios)
(see appendix). The data on the rate ratios,
controlled for age and sex, were originally esti-
mated from GLOBE using Poisson regression
(table 2). Because the rate ratios did not diVer
significantly by age and sex, except for the sig-
nificantly lower rate ratios of incidence in men
(1.35) compared with those in women (2.35),
we used the same rate ratios for both sexes and
all ages. A combination of the same rate ratios
of incidence, recovery, and mortality among
non-disabled and disabled persons for all ages
is consistent with declining relative risks on
total mortality with increasing age as observed
in literature.2 3 The rate ratio of total mortality
was substantially higher than the rate ratios of
mortality among non-disabled and disabledTable 1 Percentage of
smokers in the Netherlands,
1991, by age and sex20
Age Men Women
0–14 0 0
15–19 22 19
20–34 39 37
35–49 43 37
50–64 40 28
65+ 33 13
Table 2 Rate ratios of transitions for smokers as compared
with non-smokers (corrected for age and sex), GLOBE, the
Netherlands
Transition RR 95% CI
Incidence of disability 1.79 1.46, 2.19
Recovery from disability 0.70 0.55, 0.90
Mortality among non-disabled persons 1.24 0.87, 1.76
Mortality among disabled persons 1.24 0.87, 1.76
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persons (table 2), because the higher incidence
risks and lower recovery risks of smokers, com-
bined with the excess mortality risks in the
disabled state also contributed to the diVerence
in total mortality between smokers and non-
smokers. As the rate ratios of mortality did not
diVer significantly between non-disabled and
disabled persons, we used the same rate ratios
for both health states. Although this association
did not reach statistical significance, we used
the—statistically insignificant—rate ratio of
1.24 (95%CI: 0.87, 1.76), because the small
number of deaths in GLOBE might have been
the principal cause of this statistically non-
significant outcome. In addition, underesti-
mating the association between smoking and
mortality might artificially produce compres-
sion of morbidity when smoking is eliminated.
The rate ratio of incidence of 1.79 (95% CI
1.46, 2.19) fitted well within the range of
reported rate ratios in previous studies.5–8 The
rate ratio of total mortality of 1.6 (30–75
years), 1.45 (76–84 years) and 1.3 (85+ years)
was also in line with the results from other
European studies,2 21 considering that former
smokers were included in the reference group.
To our knowledge, no information is available
on the association between smoking and recov-
ery, and between smoking and mortality by
disability status (non-disabled and disabled).
Nor can this information be easily derived from
data on the association between smoking and
total mortality.
Finally, we compared the life expectancy
with disability between the mixed smoking-
non-smoking population (baseline) and the
non-smoking population (after eliminating
smoking) to determine whether eliminating
smoking will reduce the number of years that
people spend in a disabled state—that is,
whether absolute compression of morbidity
will occur. To assess whether the eVects of
smoking elimination diVer by age, we calcu-
lated life expectancy with and without disabil-
ity for persons aged 30 and 70. Although these
persons are on average 30.5 and 70.5 years old,
in the presentation of the results, we used age
30 and 70, respectively.
SENSITIVITY ANALYSES
In a first set of sensitivity analyses, we assessed
the sensitivity to uncertainties induced by
pooling data of the GLOBE and LSOA study.
Previous examinations of the comparability of
both datasets and the representativeness of the
outcomes for the Dutch situation indicated
that two uncertainties might have biased the
estimates of the transition rates: (1) a possible
underestimation of persons in institutions
because of sampling design in LSOA and (2) a
small jump in the proportion of men with dis-
ability between GLOBE and LSOA at age 70,
which might have biased the estimate of the
incidence rates in men.17 We examined in the
first variant the sensitivity of the outcomes for
the underrepresentation of elderly living in
institutions. In this variant we used higher
mortality rates among disabled and lower
recovery rates (change: 76–85: 10%; 86–95:
20% and 96+: 30%). In a second variant we
examined whether the small jump in incidence
of disability in men between GLOBE and
LSOA has aVected the outcomes. In contrast
with the main analyses, we used for the estima-
tion of the incidence rates the parameter for the
level (that is, á) based solely on GLOBE.
In a second set of sensitivity analyses, we
tested the sensitivity of the analysis to diVerent
values in the rate ratios, by recalculating the life
tables with excess risks that were 50% higher
and 50% lower. In this way sensitivity margins
were calculated with the upper and lower
bounds of the rate ratios.
In a third set of sensitivity analyses, we
assessed the sensitivity to specific uncertainties
related to the value of one or more rate ratios.
We specified five additional variants, to assess
the uncertainty related to (1) the lack of
evidence from other studies on the association
between smoking and recovery, (2) the absence
of a significant association between smoking
and mortality among non-disabled and dis-
abled persons, (3) the possible confounding of
the association between smoking and inci-
dence, recovery and mortality among disabled
and non-disabled persons, when smokers have
quit smoking because of a chronic condition,
(4) the sex diVerence in the rate ratio of
incidence and (5) the possible reduced excess
risks in the elderly population. In the first vari-
ant, we used a rate ratio of one for recovery
Figure 1 Prevalence of disability by age in the non-smoking and mixed
(smoking/non-smoking) population based on the multistate life table.
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(ceteris paribus) whereas in the second variant
we used a rate ratio of one for mortality among
non-disabled and disabled persons (ceteris
paribus). In the third variant, persons who
reported to have (had) serious heart diseases,
cancer, diabetes mellitus, stroke, chronic ob-
structive lung disease (COPD) or cancer at
baseline were excluded in the estimation of rate
ratios. In the fourth variant, we used a rate ratio
for incidence of 1.35 in men and 2.35 in
women (ceteris paribus). In the last variant, we
used 50% lower excess risks above age 70 for all
transitions.
Results
Figure 1 shows that at each age the prevalence
of disability is lower in the non-smoking than in
the mixed smoking-non-smoking population.
The reason is that non-smokers have a lower
incidence of disability and a higher recovery
from disability (table 2).
To assess whether non-smoking reduces the
number of disability years, the lower mortality
risks and thus the longer period in which non-
smokers will be exposed to disability should be
considered as well. By looking at (changes in)
the number of person years with and without
disability (by age) and life expectancy with and
without disability (summarised across ages)—
both outcomes of the multistate life table—it is
possible to take into account the eVects of
changes in disability and mortality at the same
time. Figure 2 shows that at younger ages the
number of person years with disability is
smaller in the non-smoking population than in
the current mixed population, whereas at older
ages the opposite is true. On balance, life
expectancy with disability at age 30 is lower in
the non-smoking than in the mixed population
(table 3). In the mixed population, total life
expectancy at age 30 is 44.8 years (men) and
50.8 years (women), of which about 38.5 years
without disability and respectively 6.4 and 12.4
years with disability. In the non-smoking popu-
lation total life expectancy is 46.4 (men) and
51.6 years (women), of which 41.0 and 40.3
years, respectively, without disability and 5.5
and 11.3 years, respectively, with disability.
These results indicate that elimination of
smoking will produce a substantially larger gain
in disability free life expectancy (2.5 years in
men and 1.9 year women) than in total life
expectancy (1.6 and 0.8 years respectively).
Consequently, smoking elimination will reduce
the number of years with disability (−0.9 and
−1.1 years respectively). This reduction in the
number of years with disability indicates that
absolute compression of morbidity will occur.
At age 70, the eVects of elimination of smoking
were in the same direction, but smaller.
Table 4 shows that the conclusion on
compression of morbidity was not aVected by
the probable underrepresentation of the insti-
tutionalised population, nor by using lower
incidence rates in men based on the GLOBE
study. In addition, the outcomes were not very
sensitive to diVerent values in the rate ratios
associated with smoking. Using 50% lower or
higher excess risks did not change the conclu-
sion. Finally, using rate ratios of one for recov-
ery (ceteris paribus), for mortality among non-
disabled and disabled persons (ceteris
paribus), or excluding in the estimation of the
rate ratios persons who reported to have (had)
a serious chronic disease at baseline, did not
change the conclusion. Nor did using 50%
lower excess risks for all transitions at age 70.
Only in the unlikely situation that the associ-
ation between smoking and incidence of
disability is substantially weaker in men, while
Figure 2 Number of person years with disability by age in the non-smoking and mixed
(smoking-non-smoking) population based on the multistate life table.
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Table 3 Total life expectancy (LE), disability free life expectancy (DFLE), life expectancy
with disability (LED) and percentage of life with disability of the mixed
smoking-non-smoking population (baseline) and of the non-smoking population (after
elimination of smoking), the Netherlands*
LE (y) DFLE (y) LED (y) %LED in LE
At age 30
Men
Mixed smoking-non-smoking (baseline) 44.8 38.5 6.4 14.2
Non-smoking population 46.4 41.0 5.5 11.8
Women
Mixed smoking-non-smoking (baseline) 50.8 38.4 12.4 24.3
Non-smoking population 51.6 40.3 11.3 21.9
At age 70
Men
Mixed smoking-non-smoking (baseline) 10.7 6.3 4.4 41.3
Non-smoking population 11.6 7.5 4.1 35.4
Women
Mixed smoking-non-smoking (baseline) 14.3 5.8 8.5 59.6
Non-smoking population 14.8 6.5 8.3 56.2
*Figures are rounded to 0.1.
Smoking and the compression of morbidity 569
www.jech.com
 on 29 November 2006 jech.bmj.comDownloaded from 
the other associations are not, will virtually no
compression of morbidity above age 70 occur
(data not shown for age 70).
Discussion
This study evaluated whether eliminating
smoking would produce compression of mor-
bidity into a shorter period, by comparing life
expectancy with disability in the current mixed
smoking-non-smoking population (baseline)
and in the non-smoking population (after
smoking elimination). Our results show that on
balance non-smokers spend fewer years with
disability than the mixed smoking-non-
smoking population. Although non-smokers
have lower mortality risks, and are thus
exposed to disability over a longer period, their
higher ability to maintain health and to restore
health losses results in a net reduction of the
length of time spent with disability and in an
increase in the life time free of disability. These
outcomes indicate that eliminating smoking
will extend the length of life and the length of
disability free life, and will compress disability
into a shorter period.
Previous studies on the eVects of smoking
have reported that smoking increases the risks
of several chronic diseases, such as (lung) can-
cer, heart disease, stroke, and chronic obstruc-
tive lung disease.3 These diseases are signifi-
cantly associated with mortality2 3 and most of
them with disability.22–24 This implies that an
eVect of smoking on disability and mortality is
biologically plausible. Nevertheless, there are
still important gaps in our understanding of the
mechanisms through which smoking aVects
disability and mortality. Smoking may have an
eVect on disability and mortality by increasing
disease incidence, decreasing disease recovery,
increasing disease severity or by increasing the
incidence of comorbid conditions. In addition,
physiological losses and symptomatology not
operating through specific diseases may have
an eVect on frailty8 and in turn on disability and
mortality. In evaluating the eVect of smoking
elimination, we used information on the
association of smoking with disability and
mortality, rather than information on the
diVerent diseases and pathways through which
smoking aVects disability and mortality. This
enabled us to take into account the overall
impact of smoking without needing infor-
mation on the exact mechanisms. To better
understand the association of smoking with
disability and mortality further research is
needed to unravel these underlying mecha-
nisms.
The limitations of our study regarding the
data should be noted. Firstly, we used data
from two diVerent countries to estimate the
transition rates between the diVerent health
states and to death. Moreover, persons living in
institutions were underrepresented in these
data because of the sampling design, especially
in the LSOA. At diVerent stages in the research
process, we examined the consequences of
pooling the GLOBE and LSOA dataset.
Firstly, we examined whether significant dis-
continuities existed between the two datasets in
the proportions of persons who died and the
proportions of persons with disability, and
whether the two datasets described the Dutch
situation.14 16 We found that the two datasets
showed no substantial discontinuities, except
the smaller proportion of disabled men in
GLOBE. With the exception of the smaller
proportions of persons dying at older ages in
LSOA (especially in women, most probably
reflecting the underrepresentation of the insti-
tutionalised population) the datasets described
the Dutch situation. Next, we examined
whether the transition rates estimated from
these datasets diVered between the two studies
regarding the level (á) and increase with age
(â). We found a diVerence in the level of
incidence in men, reflecting the diVerence in
the proportion disabled, and a diVerence in the
level of mortality among disabled women,
reflecting the underestimation of mortality in
elderly women. Finally, we examined whether
the outcomes of the multistate life table model
based on these transition rates reproduced the
Dutch situation. As could be expected, age
specific mortality rates derived from the multi-
state model were underestimated in women
above age 85. Nevertheless, survival curves
were very similar to those based on national
mortality from Statistics Netherlands and total
life expectancy at age 30 and age 70 diVered
less than 0.3 year in both sexes. The agreement
between the prevalence of disability by age
based on the multistate model and the external
data sources was also rather close. Thus, apart
from the underestimation of the institutional-
ised population in the LSOA and the possible
overestimation of incidence in men, we found
that the two datasets could be joined and
together described the Dutch situation. As, in
addition, sensitivity analyses showed that our
conclusion was robust to these two factors, we
considered the outcomes to be valid.
Table 4 Change in life expectancy with disability (LED)
at age 30 because of smoking elimination (sensitivity
analyses)†
Men Women
Baseline −0.9 −1.1
First set: pooling of datasets
1 Adj for institutionalisation‡ −0.9 −1.0
2 Adj incidence in men§ −1.0 NA
Second set: 50% sensitivity margins¶
1 Incidence −1.3, −0.5 −1.5, −0.6
2 Recovery −1.0, −0.7 −1.2, −0.9
3 Mortality non-dependent −0.9, −0.8 −1.1, −1.0
4 Mortality dependent −1.0, −0.8 −1.1, −1.0
Third set: RRs
1 No excess risks for recovery1 −0.6 −0.8
2 Only significant eVects2 −1.2 −1.3
3 Excluding chronic conditions3 −1.3 −1.4
4 Sex specific RR of incidence4 −0.4 −1.6
5 Reduction RRs by 50% above
age 70
−0.9 −1.0
†Figures are rounded to 0.1. ‡Adjustment for underestimation
population in institutions above age 76: age 30–75: no change;
age 76–85: mortality among disabled * 1.1; recovery * 0.9; age
86–95: mortality among disabled * 1.2; recovery * 0.8; age 96+:
mortality from disabled * 1.3; recovery * 0.7. §Using level of
incidence of disability based solely on the GLOBE study.
¶(1–RR) + 50%; (1–RR)—50%. 1RR of recovery 1, other RRs as
in baseline. 2RRs of mortality among non-disabled and for mor-
tality among disabled 1, other RR as in baseline. 3Persons who
reported to have (had) serious heart diseases, cancer, diabetes
mellitus, stroke, chronic obstructive lung disease (COPD) or
cancer at baseline were excluded. 4RR of incidence 1.35 in men
and 2.35 in women. NA, not applicable.
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Secondly, we used the same rate ratios at all
ages. Although evidence exists that rate ratios
of total mortality for smokers as compared with
non-smokers decrease with increasing age,2 3
we do not know studies showing a decline in
the rate ratios of incidence, recovery and mor-
tality by disability status with increasing age.
We examined whether interactions were
present between age and smoking within the
limited age range of the GLOBE study (30–74
years), but did not find any significant interac-
tions. Moreover, using the same rate ratios of
incidence, recovery, and mortality among non-
disabled and disabled persons for all ages pro-
duced declining rate ratios on total mortality
with increasing age as observed in literature.2 3
However, when in reality rate ratios of
incidence, recovery and mortality by disability
status do decrease with increasing age, our
outcomes might still be biased. Such a bias is to
be expected when the excess risks for disability
but not for mortality are lower at older ages. We
consider it more probable that if excess risks
associated with smoking are lower at older
ages, this decline would aVect all transitions, as
we expect that the same pathophysiological
mechanisms that cause excess risks of disability
for smokers, also cause higher mortality risks.
Sensitivity analysis, exploring the eVect of
lower excess risks for all transitions above age
70, showed that even a reduction of the excess
risks by 50% for all transitions would not
change our conclusion.
Two other methodological issues aVect the
interpretation of our outcomes. Firstly, we
assumed that elimination of smoking would
produce a population that experiences the
same incidence, recovery and mortality rates as
observed for non-smokers in the current mixed
smoking-non-smoking population. This as-
sumption is only valid if the diVerences
between the current mixed smoking-non-
smoking and smoking population were solely
attributable to smoking. This would imply that
the association between smoking and inci-
dence, recovery and mortality rates among
non-disabled and disabled persons, reflects a
causal relation, and is not influenced by varia-
tion in the prevalence of other risk factors or
confounded by sociodemographic characteris-
tics. Although more research is needed to vali-
date the magnitude of the causal association
between smoking and incidence, recovery and
mortality among non-disabled and disabled
persons, uncertainty about the exact magni-
tude of the rate ratios for smoking is not
expected to have biased our conclusion. Firstly,
sensitivity analyses showed that the conclusion
is not very sensitive to diVerent values in the
rate ratios associated with smoking within the
margin of 50% lower and higher excess risks
and in some other situations specified in table
4. Secondly, additional logistic regression
analyses indicated that a correction for socio-
demographic characteristics and for other life
style factors than smoking would change the
rate ratios only slightly and within the margins
of the sensitivity analyses (results not shown).
Thirdly, sensitivity analyses removing the pos-
sible confounding of the association between
smoking and incidence, recovery and mortality
among disabled and non-disabled persons,
when smokers have quit smoking because of a
chronic condition, showed no change in our
conclusion. Finally, rate ratios which could be
validated, such as those for the incidence of
disability and total mortality, were in line with
results from previous studies (see Methods
section).
Secondly, the population that will emerge
after elimination of smoking is assumed to have
the same distribution of persons who never
smoked and former smokers, and the same
average duration since smoking cessation as the
current non-smoking population. That is, some
persons never smoked, some quitted smoking
long ago and some quit smoking recently.
Although even after a long period since smok-
ing cessation, mortality and disability risks will
still be higher among former smokers than
among never smokers, because only part of the
biological damage attributable to smoking is
irreversible, persons who quitted smoking
longer ago, will have lower excess risks as com-
pared with never smokers than persons who
quitted recently.3 25 If all smokers were to quit
smoking at the same time, initially the eVect on
the population’s health would be less than esti-
mated in our study, whereas as the time since
smoking cessation evolves, the health status of
the future non-smoking population might be
more favourable than expected from our
results. To explore whether our conclusion
would be valid in the case of a future
non-smoking population in which no one had
ever smoked, we increased the excess risks
associated with smoking by 75% to obtain a
diVerence in life expectancy between smokers
and non-smokers comparable to the diVerence
currently observed between smokers and those
who have never smoked.2 Repeating our analy-
sis using these higher excess risks did not
change our conclusion. In this situation, the
reduction in life expectancy with disability
attributable to smoking elimination was −1.4
years in men and −1.7 in women at age 30 and
−0.5 and −0.4 years, respectively at age 70.
Compression of morbidity, in the presence of
an increasing life expectancy, is generally con-
sidered a favourable development of popula-
tion health. The combination of a compression
of morbidity and an increase in life expectancy
means that disability free life expectancy
increases more than total life expectancy,
KEY POINTS
x Smoking is a major preventable factor
associated with mortality and disability.
x Not smoking increases life expectancy
and the length of time spent without dis-
ability.
x Despite the fact that non-smokers are
exposed to the risk of disability over a
longer period of time, not smoking
reduces the length of time spent with dis-
ability.
x The results provide a strong additional
argument to discourage smoking.
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which implies that years in poor health are
being replaced by years in good health.
However, a compression of morbidity without
an increase in life expectancy should not
necessarily be considered a favourable develop-
ment. A compression of morbidity can be the
result of dramatic increase in premature
mortality. Nor should an absence of compres-
sion of morbidity be generally considered as
undesirable. Reduction of premature mortality
is socially desirable, even if this implies that
people live longer with disability. Nevertheless,
is clear that the consequences of smoking
elimination as shown in this study are socially
favourable. Smoking elimination would not
only produce a gain in total life expectancy (1.6
years in men and 0.8 years in women) and in
disability free life expectancy (2.5 years and 1.9
years, respectively), but in addition, the
number of years with disability would decline
(−0.9 and −1.1 years respectively).
A recent study found that non-smoking will
increase health care costs,26 which would seem
to contradict our conclusion that non-smoking
reduces the length of time spent with disability.
However, it is entirely possible that because of
smoking elimination lifetime costs will in-
crease, while the number of years with disabil-
ity will decrease. As many diseases, even when
they do not cause disability, still generate costs,
the increase in costs with increasing age
exceeds that of disability. As a result, non-
smokers saved from dying incur more costs
when they age than that they accumulate
disability.27 The finding that smoking elimina-
tion will produce compression of morbidity
supports a previous study of the eVect of non-
smoking on the number of disability years28
despite diVerences in data and methodology.
Our results have important implications for
public health policy makers and doctors. They
show that interventions aimed at eliminating
smoking will extend the length of life and will
reduce the number of years spent with disabil-
ity. This is an important finding in view of the
trade oV often found between longer life and
more years with disability. For example,
interventions aimed at eliminating fatal dis-
eases, such as cancer and heart diseases, will
extend the length of life, but at the same time
will extend the period with disability. On the
other hand, interventions aimed at eliminating
non-fatal diseases will compress disability into
a shorter period, but will not extend life.22 A
successful smoking intervention will extend
total life expectancy, extend disability free life
expectancy and reduce life expectancy with
disability. Therefore, interventions to discour-
age smoking should receive high priority. A
next step would be to pinpoint other possible
interventions that will compress of disability
into fewer years. Further research on the dis-
ablement process29 might provide clues for fac-
tors preventing, slowing down or undoing dis-
ability, which can be targeted at in further
public health interventions.
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Appendix
INCIDENCE, RECOVERY AND MORTALITY RATES
FOR THE MIXED SMOKING-NON-SMOKING
POPULATION
We used three functions to describe the
relation of the incidence, recovery and mor-
tality rates (that is, transitions rates) with age:
the exponential model (also known as the
Gompertz model), the Gompertz-Makeham
model and the Sigmoid model. The Gompertz
model is an exponential model, which reflects
an exponential decline in the power to oppose
destruction or a exponential diminution of the
vital force.30 The Gompertz-Makeham model
specifies besides the exponential component, a
component independent of age—that is, one of
chance. This constant term is the Makeham
parameter.30 Analogous to the extension of the
Gompertz model with the Makeham constant,
we use an extension of the exponential model,
which includes a component independent of
age, which specifies the upper boundary of the
transition rate. This model is called the sigmoid
model, as the curve is S shaped or sigmoid.
(1) The exponential model is specified as
follows:
or equivalently:
where: Nij is the expected number of events
(that is, transitions from state i at the beginning
of the interval to state j at the end of the inter-
val); áij is the log (expected number of events
during 1 unit of time at age 0); âij is the log
(ratio of the number of events during 1 unit of
time at age x and age x+1); X is age; Ri is expo-
sure time for state i and Mij is the transition rate
from state i to state j. Log(Ri) handles
diVerences in exposure times and is known in
statistical literature as the “oVset parameter”.
(2) The Gompertz-Makeham model is
specified as follows30:
where: Mij is the transition rate from state i to
state j, áij and âij are the regression coeYcients,
X is age, and Aij is the constant of Makeham.
The Makeham constant reflects that besides
the exponential component, there also exists a
component that is independent of age
(3) The Sigmoid model is specified as
follows:
where: óij is a constant (sigmoid constant) that
can be interpreted as an age independent
maximum transition rate.
The likelihood ratio test was used to select
between the exponential model and the
Gompertz-Makeham and Sigmoid model,
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respectively. We used a significance level of 0.01
rather than 0.05 to take into account depend-
ency between the observations in the subse-
quent waves. All models were estimated in
GLIM.31 We found that for transitions from the
non-disabled and the disabled state to dead, the
model with the fewest parameters—the
Gompertz—model could be selected to describe
the transition rates by age. However, the fit
improved significantly by using the Gompertz-
Makeham function for incidence for men
(p<0.001) and the Sigmoid function for recov-
ery for men and women (p<0.001). Although
the improvement in fit by adding the Makeham
constant did not completely reach statistical sig-
nificance for incidence in women (p=0.015), we
decided to include the Makeham constant for
women as well, to obtain the same models for
men and women. Table A1 presents the param-
eters of the regression equations for incidence of
disability, recovery from disability, mortality
among non-disabled and among disabled per-
sons for men and women. The level is expressed
by áij, the change with increasing age by âij and
M and ó are the Makeham and Sigmoid
constant, respectively. Substitution of these
parameters in the regression equation gives the
transition rates by age.
Incidence, recovery and mortality rates
for the non-smoking population
Given that for each transition, the transition
rates in the mixed smoking-non-smoking
population are the weighted average of transi-
tion rates of smokers and non-smokers, with
the proportion of smokers and non-smokers,
respectively as weights:
where: Mij is the baseline transition rate from
state i to state j; p is the proportion of smokers
(smoothed using least square regression of the
logit of the proportion on age), Mnsij is the
transition rate from state i to state j for
non-smokers; Msij is the transition rate from
state i to state j for smokers and RRij is the ratio
associated of smoking on the transition from
state i to state j.
Given that:
the transition rate in nonsmokers can be
derived, by combining the previous two
equations:
Sex and age indices are suppressed.
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